Abstract | PURPOSE:
Graft versus host disease (GVHD) is the major complication of allogeneic bone marrow transplantation (BMT) and limits the therapeutic efficacy of this modality. Although the role of natural T-regulatory cells (nTreg) in attenuating GVHD has been extensively examined, the ability of induced T-regulatory cells (iTreg) to mitigate GVHD is unknown. The purpose of this study was to examine the ability of in vitro and in vivo iTregs to abrogate GVHD. EXPERIMENTAL DESIGN: We examined the ability of in vitro differentiated and in vivo iTregs to reduce the severity of GVHD in a clinically relevant mouse model of BMT. The effect of blockade of interleukin (IL) 6 signaling on the efficacy of these Treg populations was also studied. RESULTS: In vitro differentiated iTregs fail to protect mice from lethal GVHD even when administered at high Treg:effector T-cell ratios. Lack of GVHD protection was associated with loss of Foxp3 expression and in vivo reversion of these cells to a proinflammatory phenotype characterized by secretion of IFN-γ. Phenotypic reversion could not be abrogated by blockade of IL-6 signaling or by in vitro exposure of iTregs to all-trans retinoic acid. In contrast, the in vivo induction of iTregs was significantly augmented by IL-6 blockade and this resulted in reduced GVHD. CONCLUSION: Instability of Foxp3 expression limits the utility of adoptively transferred iTregs as a source of cellular therapy for the abrogation of GVHD. Blockade of IL-6 signaling augments the ability of in vivo iTregs to prevent GVHD but has no effect on in vitro differentiated iTregs.
|
Authors | Amy Beres, Richard Komorowski, Masahiko Mihara, William R Drobyski |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 17
Issue 12
Pg. 3969-83
(Jun 15 2011)
ISSN: 1557-3265 [Electronic] United States |
PMID | 21558402
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | ©2011 AACR. |
Chemical References |
- Antibodies, Blocking
- Forkhead Transcription Factors
- Foxp3 protein, mouse
- Immunologic Factors
- Receptors, Interleukin-6
- Tretinoin
|
Topics |
- Animals
- Antibodies, Blocking
(immunology, pharmacology)
- Bone Marrow Transplantation
(adverse effects)
- Forkhead Transcription Factors
(genetics, metabolism)
- Gene Expression Regulation
(immunology)
- Graft vs Host Disease
(etiology, genetics, immunology, physiopathology)
- Immunologic Factors
(immunology, pharmacology)
- Inflammation
(immunology)
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Phenotype
- Receptors, Interleukin-6
(antagonists & inhibitors, immunology)
- Signal Transduction
(drug effects, immunology)
- T-Lymphocytes, Regulatory
(drug effects, immunology)
- Tretinoin
(immunology)
|